Sequential administration of PD‑1 inhibitor and cetuximab causes pneumonia-Reference-Cited by-同舟云学术

Sequential administration of PD‑1 inhibitor and cetuximab causes pneumonia

Published:2023-05-19 Issue:1 Volume:26 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Arai Makoto¹,Abe Mitsuhiro²,Kitahara Shinsuke²,Sakuma Noriko²,Ohno Izumi¹,Takahashi Koji¹,Imai Chiaki³,Saeki Hiromi³,Suzuki Takuji²,Uzawa Katsuhiro⁴,Hanazawa Toyoyuki⁵,Takiguchi Yuichi¹

Affiliation:

1. Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan

2. Department of Respirology, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan

3. Division of Pharmacy, Chiba University Hospital, Chiba University, Chiba 260‑8670, Japan

4. Department of Oral Science, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan

5. Department of Otorhinolaryngology/Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba 260‑8670, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference30 articles.

1. Consensus statement for the diagnosis and treatment of drug-induced lung injuries;Kubo;Respir Investig,2013

2. TATTON: A multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer;Oxnard;Ann Oncol,2020

3. Association of steroids use with survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Petrelli;Cancers (Basel),2020

4. Interstitial lung disease guideline: The British thoracic society in collaboration with the thoracic society of Australia and New Zealand and the Irish thoracic society;Bradley;Thorax,2008

5. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006